Company Data
Trevena Inc.
Ticker
TRVN
Current Price
$0.066
Market Cap
$57.0K
Price Target
Refer to Report
Volume
9
52wk Range
$0.0003 - $1.5005
Overview
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.